检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:谢彦[1] 吴克芳[1] 罗芙蓉[1] 徐泉凤[1] 杨军[1] 黄智慧[1] 王超群[1] 程光华[1]
机构地区:[1]皖南医学院弋矶山医院核医学科
出 处:《中国临床药理学与治疗学》2011年第3期313-316,共4页Chinese Journal of Clinical Pharmacology and Therapeutics
摘 要:目的:回顾分析131I治疗Graves病的临床疗效与相关的影响因素。方法:对本科406例接受131I治疗的Graves病患者进行了1年~2.5年的跟踪随访,分析一次治疗的治愈率和甲减发生率与患者的性别、年龄、甲状腺重量及131I剂量等因素的关系。结果:在随访406例病人中,治愈248例(61.08%),好转155例(38.18%),甲减118例(29.06%),无效3例(0.74%),总有效率99.26%。性别、年龄对Graves病一次131I治疗的治愈率及甲减发生率的影响差异无统计学意义(P>0.05);甲状腺重量1、31I剂量对治愈率及甲减发生率的影响有统计学差异(P<0.01)。结论:131I治疗Graves病安全、简便、效果显著,可作为Graves病的首选治疗方法。甲状腺重量1、31I剂量等因素可影响131I一次治疗Graves病的疗效及甲减发生率。AIM: To retrospectively analysis the clinical effect of 131I therapy of Graves dis- ease and some correlative factors. METHODS: The effects of some factors which including gen-der,age,thyroid weight and ^131I dose on the cure rate and the incidence rate of hypothyroidism were observed, through the follow-up of 406 ca- ses between 12 and 29 months of ^131I therapy of patients with Graves disease in our hospital. RE- SULTS:406 patients, the follow-up showed that the therapy was recovered in 248(61.08%), ef-fective 155 (38.18%), became hypothyroidism in 118(29.06%), failure in 3 (0.74%). Totally, 99.26% patients were responsed to the interven-tion. The gender and age were no significantdifference to the incidence rate of hypothyroid ism and cure rate after ^131I in the initial treat-ment of Graves disease (P) 0.05). Thyroid weight and dose of ^131I showed significant differ-ence to the incidence rate of hypothyroidism and cure rate (P〉0.01). CONCLUSION: Idine-131therapy is preffered for patients with graves dis ease because of being efficient, convenient and secure. The difference of thyroid weight and dose of ^131I do significant influence to the inci- dence rate of hypothyroidism and cure rate.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28